Authors


Stacey McCullough, PharmD

Latest:

Pharmacy's Changing Role as Cancer Care Transitions From Infused to Oral Therapies

The advent of oral oncolytics has changed the pharmacy's role in patient care beyond compounding infusions. Pharmacy staff now routinely engage patients, assessing adherence and tolerance to therapy as well as helping them navigate prescription benefits.




Marie Helweg-Larsen, PhD

Latest:

A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial

This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.


Daniel Varga, MD

Latest:

Impact of a Scalable Care Transitions Program for Readmission Avoidance

The 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.






Carol Addy, MD, MMSc

Latest:

Value-Based Health Insurance Design: How Much Does Socioeconomic Status Matter?

Socioeconomic status may significantly influence enrollee response to value-based benefit design approaches. Evaluating the association of wage status with claims experience may yield actionable insights.



L. Patrick James, MD

Latest:

Genetic Oncology Testing Is Complex, but Coverage and Reimbursement Don't Have to Be

The chief clinical officer of health plans and policy for Quest Diagnostics discusses how payers can assess the value of genetic testing in oncology.


Alex Mutebi, PhD

Latest:

Cost of Biologic Treatment Persistence or Switching in Rheumatoid Arthritis

Patients with rheumatoid arthritis who switched biologics incurred higher costs than patients who persisted on biologics. Etanercept appeared to be associated with the lowest costs.


Torkom Garabedian, MD

Latest:

Improvement of Outpatient Quality Metrics in a Limited-Resource Setting

This study presents an example of a population health initiative in a limited-resource primary care setting that led to significant improvements in preventive care quality metrics in the context of major insurance payers.


Mary A.M. Rogers, PhD, MS

Latest:

Mixed Messages to Consumers From Medicare: Hospital Compare Grades Versus Value-Based Payment Penalty

Many hospitals penalized for readmissions were given readmission grades of “no different” or “better” than the national rate on the Hospital Compare website.




Naoky Tsai, MD

Latest:

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017

From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.


Jeffrey Stewart, BA

Latest:

The Value of Specialty Pharmaceuticals - A Systematic Review

This study examines whether patients treated with specialty pharmaceuticals have improved outcomes compared with patients treated with conventional therapies, and evaluates costs associated with these treatments.



Susan M. Paddock, PhD

Latest:

Reducing Disparities Requires Multiple Strategies

Disparities in care are a complex issue requiring multiple strategies to solve, including approaches to improve the measurement of quality and reporting stratified performance estimates.


Yong Chen, MD, PhD

Latest:

Identifying Patients With Osteoporosis or at Risk for Osteoporotic Fractures

Identifying patients with osteoporosis or low bone mineral density and high risk for osteoporotic fractures is possible in administrative data using osteoporosis diagnoses and fracture risk profile.


Katherina M. Violette, BSN, RN

Latest:

No Time to Waste: Decreasing Patient Wait Times for Chemotherapy Administration Using Automated Prioritization in an Oncology Pharmacy System

Using a prioritization algorithm in an oncology pharmacy system at the Johns Hopkins University, patient wait times for chemotherapy administration were significantly decreased.



Tomas Karpati, MD

Latest:

Identifying Frail Older People Using Predictive Modeling

The frailty determination of the Adjusted Clinical Groups“diagnoses based predictive model identified frail elders with moderate success compared with a validated screening questionnaire.


Yue Zhong, MD, PhD

Latest:

Potential Role of Network Meta-Analysis in Value-Based Insurance Design

This study illustrates that where clinical trials are lacking, network meta-analysis can provide valuable insights into the potential clinical and economic benefits of value-based insurance design.



Sandeep Palakodeti, MD, MPH

Latest:

Value Realization: An Unattained Challenge for Integrated Practice Units

As value realization eludes integrated practice units (IPUs), the authors examine 6 key value drivers for IPU teams to competitively drive volumes and hone their multidisciplinary competencies.


Brook Watts, MD

Latest:

Evaluating a Hepatitis C Quality Gap: Missed Opportunities for HCV-Related Care

Management of hepatitis C screening results can be optimized to ensure that patients receive high-quality care, reducing morbidity and costs related to the virus.


Mark B. Stephens, MD, MS

Latest:

Tests, Surgical Masks, Hospital Beds, and Ventilators: Add Big Data to the List of Tools to Fight the Coronavirus That Are in Short Supply

Big data could help identify potential clues about the immediate (and future) impact of coronavirus disease 2019, but it is in short supply.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo